F Beaujean

813 total citations
30 papers, 518 citations indexed

About

F Beaujean is a scholar working on Hematology, Neurology and Genetics. According to data from OpenAlex, F Beaujean has authored 30 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 9 papers in Neurology and 5 papers in Genetics. Recurrent topics in F Beaujean's work include Hematopoietic Stem Cell Transplantation (17 papers), Neuroblastoma Research and Treatments (8 papers) and Acute Myeloid Leukemia Research (5 papers). F Beaujean is often cited by papers focused on Hematopoietic Stem Cell Transplantation (17 papers), Neuroblastoma Research and Treatments (8 papers) and Acute Myeloid Leukemia Research (5 papers). F Beaujean collaborates with scholars based in France, Switzerland and Uruguay. F Beaujean's co-authors include Olivier Hartmann, C Kalifa, Catherine Patte, E Benhamou, J Lemerle, F Flamant, Philippe Hernigou, N. Duédari, J L Pico and Odile Lejars and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

F Beaujean

30 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Beaujean France 13 230 187 142 103 98 30 518
H. Spaar Germany 13 155 0.7× 73 0.4× 124 0.9× 90 0.9× 71 0.7× 35 548
Masaaki Kumagai Japan 12 242 1.1× 102 0.5× 93 0.7× 164 1.6× 49 0.5× 28 633
LC Lasky United States 8 287 1.2× 89 0.5× 59 0.4× 153 1.5× 96 1.0× 12 413
Ellis J. Van Slyck United States 13 284 1.2× 37 0.2× 90 0.6× 84 0.8× 211 2.2× 29 528
Antonio Acquaviva Italy 12 60 0.3× 75 0.4× 165 1.2× 150 1.5× 56 0.6× 38 457
C R Nichols United States 11 192 0.8× 337 1.8× 169 1.2× 140 1.4× 50 0.5× 16 881
Pascale Halle France 11 257 1.1× 101 0.5× 56 0.4× 82 0.8× 63 0.6× 20 413
Ana Benito Spain 13 387 1.7× 37 0.2× 113 0.8× 137 1.3× 269 2.7× 26 721
Lisa Lassay Germany 9 88 0.4× 52 0.3× 78 0.5× 174 1.7× 55 0.6× 21 535
P Lyn United States 7 123 0.5× 204 1.1× 163 1.1× 110 1.1× 16 0.2× 7 542

Countries citing papers authored by F Beaujean

Since Specialization
Citations

This map shows the geographic impact of F Beaujean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Beaujean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Beaujean more than expected).

Fields of papers citing papers by F Beaujean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Beaujean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Beaujean. The network helps show where F Beaujean may publish in the future.

Co-authorship network of co-authors of F Beaujean

This figure shows the co-authorship network connecting the top 25 collaborators of F Beaujean. A scholar is included among the top collaborators of F Beaujean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Beaujean. F Beaujean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Turhan, Ali G., Jean Henri Bourhis, Marie Laure Bonnet, et al.. (1999). Unfractionated peripheral blood stem cell autografts and CD34+-enriched autografts have similar long-term culture initiating capacity in multiple myeloma. PubMed. 41(5). 197–204. 1 indexed citations
2.
3.
Hernigou, Philippe & F Beaujean. (1997). [Bone marrow in patients with pseudarthrosis. A study of progenitor cells by in vitro cloning].. PubMed. 83(1). 33–40. 33 indexed citations
4.
Moczar, M, et al.. (1995). Effects of cryopreservation on the proliferation and anticoagulant activity of human saphenous vein endothelial cells. Journal of Thoracic and Cardiovascular Surgery. 110(4). 998–1004. 19 indexed citations
5.
Beaujean, F, Françoise Bernaudin, S. Lemerle, et al.. (1995). Successful engraftment after autologous transplantation of 10-day cultured bone marrow activated by interleukin 2 in patients with acute lymphoblastic leukemia.. PubMed. 15(5). 691–6. 19 indexed citations
6.
Beaujean, F & P Hervé. (1992). New approaches for bone marrow purging. Transfusion Science. 13(4). 431–442. 1 indexed citations
7.
Beaujean, F, et al.. (1991). A simple, efficient washing procedure for cryopreserved human hematopoietic stem cells prior to reinfusion.. PubMed. 8(4). 291–4. 39 indexed citations
8.
Bretagne, Stéphane, et al.. (1990). Rapid technique for cryopreservation of Echinococcus multilocularis metacestodes. International Journal for Parasitology. 20(2). 265–267. 5 indexed citations
9.
Hartmann, Olivier, O. Oberlin, F Beaujean, et al.. (1990). [Role of high-dose chemotherapy followed by bone marrow autograft in the treatment of metastatic Ewing's sarcoma in children].. Bulletin du Cancer. 77(2). 181–7. 21 indexed citations
10.
Beaujean, F, Olivier Hartmann, E Benhamou, J Lemerle, & N. Duédari. (1989). Hemopoietic reconstitution after repeated autologous transplantation with mafosfamide-purged marrow.. PubMed. 4(5). 537–41. 11 indexed citations
11.
Ganem, G., M Kuentz, F Beaujean, et al.. (1988). Additional total-lymphoid irradiation in preventing graft failure of T-cell-depleted bone marrow transplantation from HLA-identical siblings. Results of a prospective randomized study.. PubMed. 45(1). 244–8. 5 indexed citations
12.
13.
14.
Hartmann, Olivier, E Benhamou, F Beaujean, et al.. (1987). Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma.. Journal of Clinical Oncology. 5(8). 1205–1211. 76 indexed citations
15.
Hartmann, Oliver, F Beaujean, Julien Picot, et al.. (1986). Incubation of autologous bone marrow graft with ASTA Z (7557) : Comparative studies of hematological reconstitution after purged or non-purged bone marrow transplantation. Leukemia Research. 10(1). 116–116. 1 indexed citations
16.
Hartmann, O, F Beaujean, J. L. Pico, et al.. (1985). Hematopoietic recovery following autologous bone marrow transplantation: Role of cryopreservation, number of cells infused and nature of high-dose chemotherapy. European Journal of Cancer and Clinical Oncology. 21(1). 53–60. 10 indexed citations
17.
López, Manuel, et al.. (1985). Human bone marrow processing in view of further in vitro treatment and cryopreservation. Revue Franç aise de Transfusion et Immuno-hé matologie. 28(5). 411–426. 12 indexed citations
18.
Hayat, M., et al.. (1985). A phase I-II trial of intensive chemotherapy (CT) with autologous bone-marrow transplantation (ABMT) in metastatic malignant germ cell tumors of the testis (NSGCTT).. PubMed. 203. 449–50. 2 indexed citations
19.
Hartmann, Olivier, J M Zücker, Ross Pinkerton, et al.. (1985). Metastatic neuroblastoma in children older than one year old at diagnosisTreatment with intensive chemo-radiotherapy and autologous bone marrow transplant. Revue Franç aise de Transfusion et Immuno-hé matologie. 28(5). 539–546. 5 indexed citations
20.
Dreyfus, B, Bruno Varet, Sultan C, et al.. (1975). [The treatment of disseminated intravascular coagulation in 18 cases of promyelocytic acute leukaemia (author's transl)].. PubMed. 13(6). 761–70. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Spaar Breakdown of academic impact, for papers by Masaaki Kumagai Breakdown of academic impact, for papers by LC Lasky Breakdown of academic impact, for papers by Ellis J. Van Slyck Breakdown of academic impact, for papers by Antonio Acquaviva Breakdown of academic impact, for papers by C R Nichols Breakdown of academic impact, for papers by Pascale Halle Breakdown of academic impact, for papers by Ana Benito Breakdown of academic impact, for papers by Lisa Lassay Breakdown of academic impact, for papers by P Lyn
Rankless by CCL
2026